Delivery Order SPE2DB22D2211-SPE2DB25FSABA
- Not listed
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $6,072.33 firm fixed price contract is for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of June 27, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,946.01. The contract is a firm-fixed-price, non-set-aside arrangement with an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,364,099 units of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,315.00. The contract is a firm fixed-price arrangement with a period of performance through November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $1,506.00 delivery order contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award, with a ceiling value of $9,578.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This is a firm fixed-price delivery order contract, with an ultimate completion date of May 14, 2025. The contract is not set-aside and represents open competition. AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $10,344.01, is for the provision of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This delivery order contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,156 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The award ceiling value is $1,088.36 and the ultimate completion date is April 17, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, valued at $2,882.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a period of performance through April 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,450.90 for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed price, non-set-aside award issued by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the U.S. military and other government organizations. The contract has an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSABADelivery Order
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $3,594.91. The contract is for the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML and is funded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 2, 2025 and is a firm fixed price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/1/25 |